FAQ'S
We Are Here To Answer Your Questions
The process from initial discovery to a market-ready drug can take over 10-15 years. This includes stages like target identification, lead compound optimization, pre-clinical testing, and multiple phases of clinical trials.
We identify and validate biological targets based on their role in diseases. Our team uses a combination of computational analysis, genetic data, and experimental studies to ensure a target is promising and therapeutically relevant.
Drug safety is our top priority. We conduct extensive pre-clinical safety testing in labs, followed by a rigorous three-phase clinical trial process involving human volunteers. The process is strictly monitored by regulatory bodies.
